Kambiz Yadidi

Kambiz Yadidi has had a successful career in the pharmaceutical industry. Kambiz began their career in 2000 as CEO of Med Quip. In 2008, they became the Founder and CEO of Sinus Dynamics - GHP, creating and implementing a novel topical drug/device sinus treatment nationwide and creating the largest ENT sales force in the US. In 2012, they founded Otitopic Inc. and served as its CEO. Kambiz has advanced the company towards its pivotal clinical study following an encouraging Type C meeting with the FDA. Asprihale\u00ae, the company's inhaled aspirin for patients with suspected acute myocardial infarction (MI), has the potential to revolutionize rapid platelet inhibition and PD effect for suspected acute MI patients.

Kambiz Yadidi attended the University of Southern California from 1991 to present, where they obtained a Bachelor's degree in Dentistry.